Publications & Podcasts
August 27, 2020
News Flash: HHS Issues Statement Removing Premarket Review Requirements for Laboratory Developed Tests (“LDTs”), Including COVID-19 LDTs
June 18, 2020
FDA Issues Guidance on IRB Review of Non-Emergency Individual Patient Expanded Access Requests for Investigational Drugs and Biological Products to Treat COVID-19
June 12, 2020
FDA Announces New Updates to its Guidance on Conducting Clinical Trials During COVID-19 and Notes Availability of its COVID MyStudies App
March 19, 2020
COVID-19 Expanded Access Template
January 15, 2020
More Proposed Changes to CCPA Geared to Health Care and Life Sciences Industries
October 25, 2019
Proposed Regulations Under the CCPA Provide Some Clarity, But Questions Remain
